Prostaglandin E2 receptors EP2 and EP4 are down-regulated in human mononuclear cells after injury
1Department of Surgery, New York Presbyterian Hospital-Weill Medical College of Cornell Univerity, New York, NY 10021, USA.
Background:
Recent characterization of prostaglandin receptor subtypes shows that each is critical to cellular functions and operates through separate signaling pathways that may explain differing effects of prostanoids. This study aimed to determine whether prostaglandin receptors EP2 and EP4 are modulated after injury and to evaluate the effect of prostaglandin E(2) (PGE(2)) addition and blockade on EP receptor expression.
Methods:
Peripheral blood mononuclear cells (PBMCs) isolated from 10 patients sustaining fracture or burn injury and 10 control subjects were stimulated with lipopolysaccharide +/- NS-398, an inhibitor of PGE(2) production. Samples were evaluated for production of PGE(2), tumor necrosis factor--alpha, and leukotriene B(4) as well as mRNA expression of EP receptors and COX-2. EP receptor expression was also evaluated after treating control PBMCs with PGE(2).
Results:
PBMCs from injured patients exhibited significant increases in PGE(2) production and COX-2 mRNA compared with control subjects, and these increases were inhibited by NS-398. In contrast, EP2 and EP4 receptors were markedly down-regulated after injury and NS-398 restored expression to control levels. Decreased EP2 and EP4 receptor expression after injury was replicated by coincubation of PBMCs with PGE(2).
Conclusions:
Specific PGE(2) receptors are down-regulated after injury and NS-398 reverses this response. Furthermore, PGE(2) mediates EP2 and EP4 down-regulation. These data suggest that specific EP receptor subtypes may provide critical targets for augmenting the immune response after injury in humans.
Insights
Injury down-regulates prostaglandin E2 (PGE2) receptors EP2 and EP4. Blocking PGE2 production restores receptor expression, suggesting EP receptor targets for immune response augmentation after injury.
Area of Science:
- Immunology
- Molecular Biology
- Prostanoid Signaling
Background:
- Prostaglandin receptor subtypes are crucial for cellular functions.
- Distinct signaling pathways of prostanoids may explain their varied effects.
- Understanding EP receptor modulation post-injury is vital for immune response insights.
Purpose of the Study:
- To investigate EP2 and EP4 prostaglandin receptor modulation following injury.
- To assess the impact of prostaglandin E2 (PGE2) addition and blockade on EP receptor expression.
Main Methods:
- Peripheral blood mononuclear cells (PBMCs) from injured patients and controls were analyzed.
- PGE2 production, tumor necrosis factor-alpha, and leukotriene B4 were measured.
- EP receptor and COX-2 mRNA expression were evaluated, alongside PGE2 treatment effects.
Main Results:
- Injured patients showed increased PGE2 production and COX-2 mRNA, inhibited by NS-398.
- EP2 and EP4 receptors were significantly down-regulated post-injury.
- PGE2 addition replicated the down-regulation of EP2 and EP4 receptors.
Conclusions:
- Specific PGE2 receptors (EP2, EP4) are down-regulated after injury.
- NS-398 treatment reversed this down-regulation, indicating PGE2's role.
- EP receptor subtypes represent potential targets for enhancing human immune responses post-injury.
Related Concept Videos
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Clinical Applications of Epidermal Stem Cells
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Acute Inflammation III: Local and Systemic Effects


